Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 665-670

  Phillips, William ^a   Klipper, R W ^a   Awasthi, V D ^a   Rudolph, A S ^b   Cliff, R ^b   Kwasiborski, V ^b   Goins, B A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; MACROGOL;

ANIMAL TISSUE; ARTICLE; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; NONHUMAN; OXYGEN AFFINITY; OXYGEN TRANSPORT; PRIORITY JOURNAL; RABBIT;

ANIMALS; BLOOD SUBSTITUTES; HEMOGLOBINS; LIPOSOMES; PHOSPHATIDYLGLYCEROLS; POLYETHYLENE GLYCOLS; RABBITS; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 0033036813     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Allen TM, Hansen C, Martin F, Redemann C and Yau-Young A (1991) Liposomes containing synthetic lipid derivative of poly(ethylene) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29-36.
2. Allen TM, Hansen C and Rutledge J (1989) Liposomes with prolonged circulation times: Factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta 981:27-35.
3. Boer PJD, Bleeker WK, Rigter G, Agterberg J, Stekkinger P, Kannegieter LM, Nijs IMMD and Bakker JC (1993) Intravascular reduction of methemoglobin in plasma of the rat in vivo, in Blood Substitutes and Oxygen Carriers (Chang TMS ed) pp 438-441, Marcel Dekker, Inc., New York.
4. Brandl M and Gregoriadis G (1994) Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: Vesicle characterization and in vivo behaviour. Biochim Biophys Acta 1196:65-75.
5. Chang TMS (1957) Hemoglobin corpuscles. B.Sc. honors thesis. McGill University, Montreal, Canada.
6. Conover CD, Gilbert CW, Shum KL and Shorr RGL (1997) The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Artif Organs 21:907-915.
7. Dietz AA (1944) Distribution of bone marrow, bone, and bone-ash in rabbits. Proc Soc Exp Biol Med 57:60-62.
8. Eldridge J, Russell R, Christenson R, Sakamoto R, Williams J, Parr M, Trump B, Delaney P and Mackenzie CF (1996) Liver function and morphology after resuscitation from severe hemorrhagic shock with hemoglobin solutions or autologous blood. Crit Care Med 24:663-671.
9. Farmer MC and Gaber B (1987) Liposome encapsulated hemoglobin as an artificial oxygen-carrying system. Methods Enzymol 149:184-200.
10. Gabizon A, Price DC, Huberty J, Bresalier RS and Papahadjopoulos D (1990) Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies. Cancer Res 50:6371-6378.
11. Goins B, Klipper R, Rudolph AS, Cliff RO, Blumhardt R and Phillips WT (1993) Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med 34:2160-2168.
12. M1 into liposome encapsulated hemoglobin does not extend circulation persistence at clinically relevant doses. Artif Cells Blood Substit Immobil Biotechnol 22:9-25.
13. Hess JR, Fadare SO, Tolentino LSL, Bangal NR and Winslow RM (1989) The intravascular persistence of crosslinked human hemoglobin, in The Red Cell: Seventh Ann Arbor Conference (Brewer GJ ed) pp 351-360, Alan R. Liss, New York.
14. Kaplan HM and Timmons EH (1979) The Rabbit: A Model for the Principles of Mammalian Physiology and Surgery. Academic Press, New York.
15. Katre NV (1993) The conjugation of proteins with polyethylene glycol and other polymers: Altering properties of proteins to enhance their therapeutic potential. Adv Drug Delivery Rev 10:91-114.
16. Lasic D (1996) Liposomes. Sci Med 3:34-43.
17. Needham D, McIntosh TJ and Lasic DD (1992) Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta 1108:40-48.
18. Nucci ML, Schorr R and Abuchowski A (1991) The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Delivery Rev 6:133-151.
19. Ogata Y, Goto H, Kimura T and Fukui H (1996) Development of neo red cells (NRC) with the enzymatic reduction system of methemoglobin. Artif Cells Blood Substit Immobil Biotechnol 24:396.
20. Olson JS (1996) Protein engineering strategies for designing more stable hemoglobin-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 24:397.
21. Parr MJ, Masin D, Cullis PR and Bally MB (1997) Accumulation of liposomal lipid and encapsulated doxorubicin in murine lewis lung carcinoma: The lack of beneficial effects by coating liposomes with poly(ethylene glycol). J Pharmacol Exp Ther 280:1319-1327.
22. Phillips W and Goins B (1995) Targeted delivery of imaging agents by liposomes, in Handbook of Targeted Delivery of Imaging Agents (Torchilin VP ed) pp 149-173, CRC Press, Boca Raton.
23. Phillips WT, Lemen L, Goins B, Rudolph AS, Klipper R, Fresne D, Jerabek PA, Emch ME, Martin C, Fox PT and McMahan CA (1997) Use of oxygen-15 to measure oxygen-carrying capacity of blood substitutes in vivo. Am J Physiol 272:H2492-H2499.
24. Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R and Blumhardt R (1992) A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl Med Biol 19:539-547.
25. Reinish LW, Bally MB, Loughrey HC and Cullis PR (1988) Interactions of liposomes and platelets. Thromb Haemost 60:518-523.
26. Rudolph AS, Klipper RW, Goins B and Phillips WT (1991) In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc Natl Acad Sci USA 88:10976-10980.
27. Sakai H, Takeoka S, Park SI, Kose T, Nishide H, Izumi Y, Yoshizu A, Kobayashi K and Tsuchida E (1997) Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjug Chem 8:23-30.
28. Smyth HF, Carpenter CP and Shaffer CB (1947) The toxicity of high molecular weight polyethylene glycols: Chronic oral and parenteral administration. J Am Pharm Assoc 36:157-160.
29. Spence RK (1995) Perfluorocarbons in the twenty-first century: Clinical applications as transfusion alternatives. Artif Cells Blood Substit Immobil Biotechnol 23:367-380.
30. Takahashi A (1995) Characterization of neo red cells (NRCs), their function and safety in vivo tests. Artif Cells Blood Substit Immobil Biotechnol 23:347-354.
31. Takeoka S, Sakai H, Ohgushi T and Nishide H (1996) Construction of artificial reduction systems in Hb-vesicles. Artif Cells Blood Substit Immobil Biotechnol 24:440.
32. Torchilin VP, Klibanov AL, Huang L, O'Donnell S, Nossiff ND and Khaw BA (1992) Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J 6:2716-2719.
33. Torchilin VP, Omelyanenko VG, Papisov MI, Bogdanov AA Jr, Trubetskoy VS, Herron JN and Gentry CA(1994) Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1195: 11-20.
34. Tsuchida E (1994) Stabilized hemoglobin vesicles. Artif Cells Blood Substit Immobil Biotechaol 22:467-477.
35. Vandegriff KD (1995) Stability and toricity of hemoglobin solutions, in Blood Substitutes: Physiological Basis of Efficacy (Winslow RM, Vandegriff KD and Intaglietta M eds) pp 105-131, Birkhauser, Boston.
36. Winslow RM (1992) Hemoglobin-Based Red Cell Substitutes. The Johns Hopkins University Press, Baltimore.
37. Woodle MC, Newman MS and Working PK (1995) Biological properties of sterically stabilized liposomes, in Steath Liposomes (Lasic D and Martin F eds) pp 103-117, CRC Press, Boca Raton.
38. Yoshioka H (1991) Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma. Biomaterials 12:861-864.
39. Zheng S, Zheng Y, Beissinger R and Martin FJ (1994) Efficacy, physical properties and pharmacokinetics of sterically-stabilized liposome-encapsulated hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 22:487-501.